Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

As populations increase their life expectancy, age-related neurodegenerative disorders such as Alzheimer's disease have become more common. I2-Imidazoline receptors (I2-IR) are widely distributed in the central nervous system, and dysregulation of I2-IR in patients with neurodegenerative diseas...

Full description

Saved in:
Bibliographic Details
Published inNeurotherapeutics Vol. 16; no. 2; pp. 416 - 431
Main Authors Griñán-Ferré, Christian, Vasilopoulou, Foteini, Abás, Sònia, Rodríguez-Arévalo, Sergio, Bagán, Andrea, Sureda, Francesc X., Pérez, Belén, Callado, Luis F., García-Sevilla, Jesús A., García-Fuster, M. Julia, Escolano, Carmen, Pallàs, Mercè
Format Journal Article
LanguageEnglish
Published Cham Elsevier Inc 01.04.2019
Springer International Publishing
Springer Nature B.V
Springer Verlag
Subjects
Online AccessGet full text
ISSN1878-7479
1933-7213
1878-7479
DOI10.1007/s13311-018-00681-5

Cover

More Information
Summary:As populations increase their life expectancy, age-related neurodegenerative disorders such as Alzheimer's disease have become more common. I2-Imidazoline receptors (I2-IR) are widely distributed in the central nervous system, and dysregulation of I2-IR in patients with neurodegenerative diseases has been reported, suggesting their implication in cognitive impairment. This evidence indicates that high-affinity selective I2-IR ligands potentially contribute to the delay of neurodegeneration. In vivo studies in the female senescence accelerated mouse-prone 8 mice have shown that treatment with I2-IR ligands, MCR5 and MCR9, produce beneficial effects in behavior and cognition. Changes in molecular pathways implicated in oxidative stress, inflammation, synaptic plasticity, and apoptotic cell death were also studied. Furthermore, treatments with these I2-IR ligands diminished the amyloid precursor protein processing pathway and increased Aβ degrading enzymes in the hippocampus of SAMP8 mice. These results collectively demonstrate the neuroprotective role of these new I2-IR ligands in a mouse model of brain aging through specific pathways and suggest their potential as therapeutic agents in brain disorders and age-related neurodegenerative diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1878-7479
1933-7213
1878-7479
DOI:10.1007/s13311-018-00681-5